Takeda, Affymax announce additional peginesatide Phase 3 study results in ... - News-Medical.net PDF Print
News-Medical.net
These data, along with a demographic analysis from the dialysis studies, were part of three poster presentations at the National Kidney Foundation's (NKF) Spring Clinical Meetings in Las Vegas, Nevada. Peginesatide is in development for the treatment

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.